Corneal blindness and xenotransplantation
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Approximately 39 million people are blind worldwide, with an estimated 285 million visually impaired. The developing world shoulders 90% of the world's blindness, with 80% of causative diseases being preventable or treatable. Blindness has a major detrimental impact on the patient, community, and healthcare spending. Corneal diseases are significant causes of blindness, affecting at least 4 million people worldwide. The prevalence of corneal disease varies between parts of the world. Trachoma, for instance, is the second leading cause of blindness in Africa, after cataracts, but is rarely found today in developed nations. When preventive strategies have failed, corneal transplantation is the most effective treatment for advanced corneal disease. The major surgical techniques for corneal transplantation include penetrating keratoplasty (PK), anterior lamellar keratoplasty, and endothelial keratoplasty (EK). Indications for corneal transplantation vary between countries, with F uchs' dystrophy being the leading indication in the USA and keratoconus in A ustralia. With the exception of the USA, where EK will soon overtake PK as the most common surgical procedure,PK is the overwhelming procedure of choice. Success using corneal grafts in developing nations, such as N epal, demonstrates the feasibility of corneal transplantation on a global scale. The number of suitable corneas from deceased human donors that becomes available will never be sufficient, and so research into various alternatives, for example stem cells, amniotic membrane transplantation, synthetic and biosynthetic corneas, and xenotransplantation, is progressing. While each of these has potential, we suggest that xenotransplantation holds the greatest potential for a corneal replacement. With the increasing availability of genetically engineered pigs, pig corneas may alleviate the global shortage of corneas in the near future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Processing Porcine Cornea for Biomedical Applications
Oh, J. Y., Kim, M. K., Lee, H. J., Ko, J. H., Wee, W. R., & Lee, J. H. (2009) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2009.0022 · Cited by 80
Cited by
In Vivo Confocal Microscopy of Corneal Nerves in Health and Disease
Cruzat, A., Qazi, Y., & Hamrah, P. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2016.09.004 · Cited by 364
Marine Collagen as A Promising Biomaterial for Biomedical Applications
Lim, Y.-S., Ok, Y.-J., Hwang, S.-Y., Kwak, J.-Y., & Yoon, S. (2019) · Marine Drugs · doi:10.3390/md17080467 · Cited by 328
Development of fish collagen in tissue regeneration and drug delivery
Furtado, M., Chen, L., Chen, Z., Chen, A., & Cui, W. (2022) · Engineered Regeneration · doi:10.1016/j.engreg.2022.05.002 · Cited by 199
Decellularization methods for developing porcine corneal xenografts and future perspectives
Isidan, A., Liu, S., Li, P., Lashmet, M., Smith, L. J., Hara, H., Cooper, D. K. C., & Ekser, B. (2019) · Xenotransplantation · doi:10.1111/xen.12564 · Cited by 79
Self-citationSharifi, R., Yang, Y., Adibnia, Y., Dohlman, C. H., Chodosh, J., & Gonzalez-Andrades, M. (2019) · Scientific Reports · doi:10.1038/s41598-018-38342-4 · Cited by 51
Metadata
- Authors
- Lamm, V., Hara, H., Mammen, A., Dhaliwal, D., & Cooper, D. K. C.
- Venue
- Xenotransplantation
- Publisher
- Wiley
- Published
- 2014-02-21
- Volume
- 21
- Issue
- 2
- Pages
- 99-114
- ISSN
- 0908-665X (ISSN-L)
- 1399-3089
- OpenAlex
- W2079039555
- Cited by
- 105
- References
- 1
- FWCI
- 6.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.